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Pseudomonas aeruginosa is a well-known pathogenic bacterium that forms biofilms
and produces virulence factors, thus leading to major problems in many fields, such
as clinical infection, food contamination, and marine biofouling. In this study, we
report the purification and characterization of an exopolysaccharide EPS273 from the
culture supernatant of marine bacterium P. stutzeri 273. The exopolysaccharide EPS273
not only effectively inhibits biofilm formation but also disperses preformed biofilm of
P. aeruginosa PAO1. High performance liquid chromatography traces of the hydrolyzed
polysaccharides shows that EPS273 primarily consists of glucosamine, rhamnose,
glucose and mannose. Further investigation demonstrates that EPS273 reduces the
production of the virulence factors pyocyanin, exoprotease, and rhamnolipid, and the
virulence of P. aeruginosa PAO1 to human lung cells A549 and zebrafish embryos
is also obviously attenuated by EPS273. In addition, EPS273 also greatly reduces
the production of hydrogen peroxide (H2O2) and extracellular DNA (eDNA), which
are important factors for biofilm formation. Furthermore, EPS273 exhibits strong
antioxidant potential by quenching hydroxyl and superoxide anion radicals. Notably,
the antibiofouling activity of EPS273 is observed in the marine environment up to
2 weeks according to the amounts of bacteria and diatoms in the glass slides
submerged in the ocean. Taken together, the properties of EPS273 indicate that it has a
promising prospect in combating bacterial biofilm-associated infection, food-processing
contamination and marine biofouling.
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INTRODUCTION
Pseudomonas aeruginosa is a Gram-negative, rod-shaped bacterium that belongs to the family
Pseudomonadaceae, which is widespread in nature, inhabiting soil, water, plant, animals, and
human beings (Franzetti and Scarpellini, 2007). It is an opportunistic pathogen and rarely
cause disease in healthy persons, but is a notorious nosocomial pathogen, posing a high risk
to immunosuppressed individuals and other highly vulnerable patients (Balasubramanian et al.,
2013). P. aeruginosa can cause pneumonia, catheter-associated and urinary tract infections,
and sepsis in wounded patients, sometimes resulting in serious chronic infections and health
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complications. In particular, it is fatal to patients with cystic
ﬁbrosis by forming mucoid in lung tissue (Bjarnsholt et al., 2009).
In addition, P. aeruginosa has also been implicated as the most
common bacterial pathogen in marine aquaculture (Thomas
et al., 2014), and is considered as the causes of spoilage in aquatic
product (Gram and Huss, 1996). Furthermore, P. aeruginosa is
also a major food spoilage microorganism in food processing
industry, such as in brewing, dairy processing, fresh produce,
poultry processing, and red meat processing (Srey et al., 2013).
The worst of all, P. aeruginosa can colonize on various surfaces
by forming a bioﬁlm (Flemming and Wingender, 2010), and the
cells in bioﬁlm are more resistant to antibiotics and biocides
than planktonic cells, thus causing diﬃculties in eradicating them
completely (Hoyle and Costerton, 1991).
Bioﬁlm is a bacteria community which adhere to biotic and
abiotic surface and embedded in a polymeric matrix composed
mainly of polysaccharides, proteins, nucleic acids (Flemming
and Wingender, 2010). Bioﬁlm is the predominant mode of
growth for bacteria in natural, clinical, industrial and food-
processing environments. It is now recognized that many
outbreaks of pathogens have been found to be associated with
bioﬁlms (Lapidot et al., 2006; Aarnisalo et al., 2007), and
bacterial bioﬁlms are accounting for over 80% of microbial
infections in the body (Moreau-Marquis et al., 2008). Within
bioﬁlms bacteria are generally well protected against the inﬂuence
of disinfectants, antibiotics and the host immune system.
Compared with the planktonic ones, bacteria within bioﬁlm
are upwards of 1000-times more resistant to conventional
antibiotic treatment and host immune responses, leading to
bioﬁlms extremely diﬃcult to eradicate (Burmolle et al., 2010).
Therefore, searching for novel compounds or strategies to
inhibit bioﬁlm formation or disperse preformed bioﬁlm is
needed.
Bioﬁlm is also the root cause of biofouling in most
cases (Daﬀorn et al., 2011). Biofouling in aquaculture is a
speciﬁc problem where both the target culture species and/or
infrastructure are exposed to a diverse array of fouling organisms,
with signiﬁcant production impacts (Fitridge et al., 2012). To
combat biofouling, one strategy is to control bioﬁlm development
during the ﬁrst step of fouling adhesion by antifouling paints, but
the traditional antifouling paints are toxic and have the potential
to cause environmental problem (Daﬀorn et al., 2011; Wu et al.,
2015). Therefore, it is essential to look for environmental friendly
antibioﬁlm agents to combat biofouling.
It is well known that the biodiversity of the marine
environment and the associated chemical diversity constitute
a practically unlimited resource of new bioactive substances
(Carte, 1993), and the bioactive compounds from marine
microorganisms have been exploited for decades (Jiang et al.,
2011). However, their application in treating detrimental bioﬁlms
is still a relatively less-explored area (Miao and Qian, 2005).
In this study, we show that an exopolysaccharide EPS273
puriﬁed from culture supernatant of the marine bacterium P.
stutzeri 273 not only inhibits bioﬁlm formation but also disrupts
the established bioﬁlms of P. aeruginosa PAO1. EPS273 also
increases the survival rates of human lung cells and zebraﬁsh
embryos in the presence of P. aeruginosa PAO1. Furthermore,
the strong antioxidant and antibiofouling activities of EPS273 are
also reported.
MATERIALS AND METHODS
Bacterial Strains Isolation, Identification
and Culture Conditions
The marine bacteria strains used in this study were isolated
from the sediments of East China Sea and cultured in marine
broth 2216E (5 g/L tryptone, 1 g/L yeast extract, one liter
ﬁltered seawater, pH adjusted to 7.4–7.6) or Luria Bertani (LB)
medium (10 g/L peptone, 5 g/L yeast extract, 10 g/L NaCl,
pH adjusted to 7.0), and incubated at 28◦C. Genomic DNA
was extracted from the isolate, and PCR (polymerase chain
reaction) was performed to amplify the 16S rRNA gene sequence
with universal primers 27F (AGAGTTTGATCCTGGCTCAG)
and 1541R (AAGGAGGTGATCCACCC). The 16S rRNA gene
sequence was analyzed by using the BLAST programs1 to
determine the phylogenetic position of the bacterium strain 273.
P. aeruginosa PAO1was cultured in LBmedium and incubated at
37◦C.
Purification of Antibiofilm Component
EPS273 from Marine Bacterium
Pseudomonas Stuzeri 273
The marine bacterium P. stutzeri 273 was cultured in glass
ﬂasks containing LB medium and incubated at 28◦C under
vigorous agitation for 48 h. Cell-free culture supernatant of
the strain P. stutzeri 273 was collected by centrifugation at
12,000 rpm for 15 min, and precipitated overnight at 80%
saturation with (NH4)2SO4 at 4◦C. The precipitate was collected
by centrifugation and dissolved in 50 mM NaCl in 20 mM Tris-
HCl (pH 9.0), and dialyzed against the same buﬀer overnight.
The dialyzed fraction was loaded onto a 5 mL HiTrapTM Q HP
column (GE Healthcare) pre-equilibrated with 50 mM NaCl in
20 mM Tris-HCl (pH 9.0), then eluted with a NaCl gradient
(50-500 mM) in the same buﬀer at 5 mL/min. Active fractions
were collected, concentrated by ultra-ﬁltration (100-kDa MW
cut-oﬀ membrane, Millipore), and subjected to gel ﬁltration on
a HiloadTM 16/600 SuperdexTM 200 column (GE Healthcare)
pre-equilibrated with 150 mM NaCl in 20 mM Tris-HCl (pH
9.0). The column was eluted with the same buﬀer at a ﬂow
rate of 1 mL/min, and the active fractions were pooled for
further analysis. All puriﬁcation was performed at 4◦C. Total
sugar content was determined by the phenol-sulfuric acidmethod
using glucose as the standard (Jiang et al., 2011), and active
fractions were determined as described in the following section
of inhibition assay of bioﬁlm formation.
The Inhibition Assay of Biofilm Formation
with Supernatant of P. stutzeri 273
The inhibition assay of bioﬁlm formation was performed
according to the method as described previously
1http://blast.ncbi.nlm.nih.gov/Blast.cgi
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(Sambanthamoorthy et al., 2014; Wu et al., 2015). Brieﬂy,
the overnight culture of P. aeruginosa PAO1 was diluted with
LB medium to OD600 of 0.1, and incubated statically in 96-
well polystyrene plate with or without 10% (volume/volume)
supernatant of P. stutzeri 273 at 37◦C for 24 h. For the
quantiﬁcation of bioﬁlm, planktonic bacteria were discarded,
and the wells were rinsed gently with sterile distilled water,
air-dried for 10 min and stained with 1% crystal violet for
10 min. The stained bioﬁlm was washed again with sterile
distilled water followed by the addition of 200 µl of ethanol
(95%, volume/volume) to dissolve the crystal violet, and the
absorbance was determined at 595 nm.
We also checked the inhibition activity on rectangular glass
slides, which were placed in 12-well polystyrene plate containing
LB broth with OD600 about 0.1 P. aeruginosa PAO1. The
wells containing the glass slides were supplemented with or
without 10% (volume/volume) supernatant of P. stutzeri 273 and
incubated at 37◦C. The glass slides were taken out and gently
washed with sterile water after incubated for 24 h. Bioﬁlms on
the glass slides were stained with crystal violet as described above
and recorded with photograph.
The Dispersion Assay of Preformed
Biofilm with Supernatant of
P. stutzeri 273
For the bioﬁlm dispersion assay, the overnight culture of
P. aeruginosa PAO1 was diluted with LB medium to OD600
of 0.1, and incubated statically in 96-well polystyrene plate
at 37◦C to allow the bioﬁlm formation. Following the
bioﬁlm formation after incubation for 24 h, the bioﬁlm was
treated with or without 10% (volume/volume) supernatant
of P. stutzeri 273 and incubated overnight. The bioﬁlm
quantiﬁcation was performed using the crystal violet
staining technique according to the method as described
above.
We also checked the dispersion activity on rectangular glass
slides, which were placed in 12-well polystyrene plate containing
LB broth with OD600 about 0.1 P. aeruginosa PAO1. After
the bioﬁlms formed on glass pieces at 37◦C for 24 h, the
wells containing the glass slides were supplemented with 10%
(volume/volume) supernatant of P. stutzeri 273 and incubated
overnight. The glass slides were taken out and gently washed with
sterile water. Bioﬁlms on the glass slides were stained with crystal
violet and recorded with photograph.
Physical and Chemical Analysis of
Antibiofilm Component of EPS273
For enzymatic treatment, the puriﬁed EPS273 aliquots with a ﬁnal
concentration of 0.1 µg/mL were incubated at 37◦C for 1 h with
100 µg/mL DNase I, RNase A or 1 mg/mL proteinase K (Sigma–
Aldrich). For sodium metaperiodate treatment, EPS273 aliquot
with a ﬁnal concentration of 0.1 µg/mL was incubated at with
10mM sodiummetaperiodate 37◦C for 12 h. As controls, EPS273
aliquots were incubated at 37◦C for corresponding time in the
absence of enzymes or sodium metaperiodate. For each of the
above tests, the antibioﬁlm activities of EPS273 aliquots with or
without treatment were compared using 96-well polystyrene plate
assay against P. aeruginosa PAO1.
For infrared (IR) spectroscopy, as previously described (Sun
et al., 2009), EPS273 was mixed with KBr powder, ground
and then pressed into a 1 mm pellets for fourier transform
infrared (FT-IR) measurement in the frequency range of 4000–
500 cm−1, FT-IR spectra of EPS273 was measured on a
Nicolet Nexus 470 spectrometer. The molecular weight was
assessed by High Performance Gel Permeation Chromatography
(HPGPC; Sun et al., 2009). The monosaccharide components
were determined by High-performance liquid chromatography
(HPLC; Sun et al., 2009). The standard saccharides used here were
glucose, galactose, mannose, rhamnose, xylose, glucuronic acid,
galacturonic acid, and glucosamine.
Fluorescence Microscopic Observation
of Biofilm Inhibition and Dispersion by
EPS273
For the inhibition assay of bioﬁlm formation, the wells of
polystyrene plate containing rectangular glass slides and LB broth
with OD600 about 0.1 P. aeruginosa PAO1 were supplemented
with or without 0.1 µg/mL, 0.5 µg/mL of puriﬁed EPS273 and
incubated at 37◦C for 24 h. Bioﬁlms on the glass slides were
stained with 0.01% acridine orange solution for 5 min and
observed under ﬂuorescence microscope (Imaginer A2, Zeiss,
Germany).
For the dispersion assay of the preformed bioﬁlm, after the
bioﬁlm formed on the glass slides in the 12-well polystyrene plate,
the wells containing the glass slides were supplemented with or
without 0.1 µg/mL, 0.5 µg/mL of puriﬁed EPS273 and incubated
at 37◦C overnight. Bioﬁlms on the glass slides were stained with
0.01% acridine orange solution for 5 min and observed under
ﬂuorescence microscope (Imaginer A2, Zeiss, Germany).
Antibiofilm and Antimicrobial Assays
with EPS273
The antibioﬁlm and antimicrobial activities of puriﬁed EPS273
on P. aeruginosa PAO1 were checked in 96-well polystyrene
microplate according to the method described previously with
minor modiﬁcation (Sambanthamoorthy et al., 2014; Wu et al.,
2015). Brieﬂy, the overnight culture of P. aeruginosa PAO1
was diluted with LB medium to OD600 of 0.1, and incubated
statically in 96-well polystyrene plate with or without 10% cell-
free supernatant, 0.1 µg/mL or 0.5 µg/mL puriﬁed EPS273,
respectively, at 37◦C for 24 h. For the bioﬁlm quantiﬁcation,
the bioﬁlm was stained with crystal violet. For the planktonic
cells, the contents of each well were plated onto LB agar plates
with appropriate dilutions, and colony-forming unit (cfu) were
enumerated the next day. The bioﬁlm or the cfu of P. aeruginosa
PAO1 incubated with the same amount of buﬀer was set as 100%.
Effects of EPS273 on Production of
Virulence Factors, H2O2 and eDNA by
P. aeruginosa PAO1
Pseudomonas aeruginosa PAO1 was inoculated in glass ﬂasks
containing LB broth without or with EPS273 (ﬁnal concentration
Frontiers in Microbiology | www.frontiersin.org 3 February 2016 | Volume 7 | Article 102
Wu et al. Antibiofilm and Anti-Infection of an Exopolysaccharide
at 0.1 µg/mL), and incubated at 37◦C statically. At diﬀerent
growth times, P. aeruginosa PAO1 cells were separated from
culture via centrifugation at 12, 000 rpm for 15 min, and the
culture supernatants were passed through 0.22-µm syringe-
driven ﬁlters (Millipore).
The quantity of pyocyanin was measured according to the
method described previously (Musthafa et al., 2012). Brieﬂy,
crude pyocyanin was initially extracted by mixing 5 mL cell-free
supernatants with 3 mL chloroform. The pyocyanin in the layer
of chloroform was then re-extracted with 1 mL 0.2 N HCl to
get a pink to deep-red solution. The quantity of pyocyanin was
measured at 520 nm using spectrophotometer.
The proteolytic activity was determined according to the
method described previously with some modiﬁcation (Kessler
et al., 1993). Brieﬂy, 200 µl of cell free supernatant was mixed
with 50 µl of 0.3% azocasein in 0.05 M Tris-HCl (pH7.5),
and the reaction mixture was subsequently incubated at 37◦C
for 60 min. The reaction was stopped by the addition of 10%
trichloroacetic acid. Exoprotease activity was measured at 440 nm
by spectrophotometer.
For assaying rhamnolipid activity, 5 mL cell-free supernatant
was acidiﬁed to pH 2.0 with concentrated HCl, and then
two volumes of chloroform/ethanol (2:1, v/v) were added to
extract rhamnolipid by vigorous mixing. The organic phase
was evaporated to dryness, and the rhamnolipid residue
was dissolved in 1 mL deionized water. The quantity of
rhmnolipid was measured according to the method described
previously (Kim et al., 2015). Brieﬂy, 100 µl rhamnolipid
solution was mixed with 900 µl orcinal solution (0.19%
orcinal (Sigma–Aldrich) in 53% H2SO4. The mixture was
boiled for 30 min, and then cooled at room temperature for
15 min. Rhamnolipid activity was measured at 421 nm using
spectrophotometer.
For H2O2 generation, a colorimetric assay was applied as
described previously (Das and Maneﬁeld, 2012). Brieﬂy, the
freshly prepared solution of 160 µl of sodium acetate (0.1 M)
containing 0.1 µg of horseradish peroxidase and 10 µl of
1 mg/mL o-dianisidine in methanol, 40µl of cell free supernatant
was added in 96-wells microtiter plate and incubated for 10 min
at room temperature protected from light. The absorbance of
H2O2 in the mixture solution was determined using a microplate
reader at 570 nm.
For the quantiﬁcation of eDNA, 50 µl of cell free
supernatants were incubated with 50 µl of Quant-it Picogreen
reagent (Invitrogen). The mixture was excited at 485 nm
and ﬂuorescence intensity was measured at 520 nm. The
measured amount of eDNA was determined by the standard
curve according to the quant-it picogreen ds DNA kit
(Invitrogen).
Inhibition Activities of EPS273 on
P. aeruginosa PAO1 Infection Toward
Human Lung Carcinosis A549 Cells
Pseudomonas aeruginosa PAO1 infection assay was performed
according to O’Loughlin et al. (2013) with minor modiﬁcation.
Human A549 cells were grown in CellStar tissue culture ﬂasks
(Nest, China). Before infection, the A549 cells were treated with
trypsin-EDTA, split, counted, aliquoted into 96-well plates at
20,000 mammalian cells per well, and incubated at 37◦C in
the presence of 5% CO2. After incubated for 24 h, cells were
washed three times with pre-warmed PBS before 90 µl of PBS
containing propidium iodide (10 µg/mL) was added to each well,
then 10 µl of OD600 > 1.0 P. aeruginosa PAO1 preincubated
or non-preincubated with diﬀerent concentrations of EPS273
(0.1 µg/mL, 0.5 µg/mL) was added. In addition, 10 µl of
OD600 > 1.0 P. aeruginosa PAO1 non-preincubated with EPS273
was also added parallel with diﬀerent concentrations of EPS273
(0.1 µg/mL, 0.5 µg/mL). Cells were further incubated at 37◦C,
and infections were monitored using a microplate reader after
incubated for 8 h with Red FP ﬁlter. For the cytotoxic assay
of EPS273 to human cells, diﬀerent concentration of EPS273
(0.1, 0.5, and 1 µg/mL) was added parallel to human A549
cells, and cells were incubated at 37◦C. The percent cell death
was calculated using uptake into A549 lung cells after 8 h and
normalized to lung cells treated with P. aeruginosa PAO1 in the
absence of EPS273, of which the cell death was set as 100%. All
human cell experiments were carried out in accordance with the
ethical guidelines of Chinese Academy of Sciences.
Inhibition Activities of EPS273 on
P. aeruginosa PAO1 Infection Toward
Zebrafish
Wild type zebraﬁsh were maintained at 28◦C on a 10 h
light/14 h dark cycle and food was freely available. The
zebraﬁsh embryos were generated by natural pair-wise mating
(3–12 months old) as described before (Westerﬁeld, 1993).
Healthy, transparent and regular embryos were selected and
aliquotted into 96-well plates with ﬁve embryos per well,
then incubated at 28◦C in 200 µl embryo water. Thereafter,
5 µl of P. aeruginosa PAO1 preincubated or non-preincubated
with diﬀerent concentrations of EPS273 for 6 h was added
to the embryos at 24 h post-fertilization (hpf). In addition,
5 µl of P. aeruginosa PAO1 non-preincubated with EPS273
was also added parallel with diﬀerent concentrations of
EPS273. The zebraﬁsh embryos were further incubated at
28◦C, and development of the embryos was observed using
an inverted microscope (NIKON TS100, Japan) equipped with
a digital camera. All animal experiments were conducted in
accordance with the ethical guidelines of Chinese Academy of
Sciences.
Antioxidant Activities of EPS273 by
Scavenging Hydroxyl Radical and
Superoxide Radical
Hydroxyl radical-scavenging activity of EPS273 was determined
according to the method described previously with little
modiﬁcation (Yin et al., 2010). Brieﬂy, 50 µl of PBS (20 mM,
pH 7.4), 25 µl of 1,10 - phenanthroline solution (2.5 mM),
25 µl FeSO4 solution (2.5 mM), and 25 µl of H2O2 (20 mM)
were added successively in a tube and mixed thoroughly. Then
100 µl of EPS273 aliquot with various concentrations was
added in the mixture and incubated at 37◦C for 1 h. The
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absorbance was measured at 536 nm immediately and hydroxyl
radical scavenging activity was expressed as Scavenging activity
(%) = (As-Ac/Ao-Ac) × 100. Where As is absorbance of the
sample in the presence of diﬀerent concentrations of EPS273,
Ac is absorbance of the sample in the absence of EPS273,
and Ao is absorbance of the sample without both EPS273 and
H2O2.
Superoxide radical-scavenging activity of EPS273 was
performed according to Zhang et al. (2011) with minor
modiﬁcation. An aliquot of 50 µl of Tris-HCl buﬀer (pH 8.0,
150 mM) was mixed with 25 µl of 1,2,3-phentriol (1.50 mM,
dissolved with 10 mM HCl) and 100 µl of EPS273 aliquot
with various concentrations. After thorough mixing, the
mixture was incubated at room temperature for 30 min. The
absorbance of the mixture was measured at 325 nm and
superoxide radicals scavenging generated by 1,2,3-phentriol
autoxidation was calculated as follows: Scavenging activity
(%)= [1- (A11−A10/A01−A00)] × 100. Where A00 is absorbance
of the sample in absence of EPS 273 and 1,2,3-phentriol, A01 is
absorbance of the sample contained 1,2,3-phentriol but no EPS
273, A10 is absorbance of the sample contained EPS 273 but no
1,2,3-phentriol, and A11 is absorbance of the sample contained
EPS 273 and 1,2,3-phentriol.
Antibiofouling Activity of EPS273 Tested
in the Ocean Environment
The paint containing diﬀerent concentrations of EPS273 or the
same amount EPS273 stocking buﬀer was coated to the glass
slides and dried in the air. Thereafter, the dried glass slides
were immersed in the ocean environment of Zhonggang harbor,
Qingdao, China. After one or 2 week(s), the glass slides were
taken out for imaging and bacteria/diatoms numbers counting.
Brieﬂy, the glass slides were rinsed with sterile seawater three
times, then the paint sheets were removed completely with
knife and put into the tube with sterile seawater. The tubes
were vibrated vigorously, and one part of the suspension was
diluted in marine broth and plated in marine agar plate for
bacteria number counting, the other part was diluted in the
sterile seawater and used to count the diatoms numbers under
microscope.
Statistical Analysis
The results were presented as the mean ± SD (standard
deviations) and were analyzed by a student’s t-test. The values of
P < 0.05 were used to identify statistically signiﬁcant diﬀerences.
All measurements were performed in triplicate.
RESULTS
Antibiofilm Activity of P. stutzeri 273
Culture Supernatant Against
P. aeruginosa PAO1
In order to obtain potential bioﬁlm formation inhibitors, the
culture supernatants of more than 400 marine bacterial strains
were screened and evaluated by their abilities to inhibit bioﬁlm
formation by P. aeruginosa PAO1 using 96-well polystyrene
plate. Among them, the strain 273 exhibited the strongest
ability to inhibit bioﬁlm formation. As shown in Figure 1A,
the supernatant of strain 273 almost abolished the bioﬁlm
formation completely at the dilution of 1/10, which was
further conﬁrmed by the analysis on glass slides as shown in
Figure 1B.
While the culture supernatant of marine bacterium strain 273
could greatly inhibit bioﬁlm formation by P. aeruginosa PAO1,
we sought to explore whether the culture supernatant could
disperse the preformed bioﬁlm in the 96-well polystyrene plate.
This assay was performed by shifting the preformed bioﬁlms to
medium supplemented with culture supernatant of bacterium
strain 273 at the dilution of 1/10, and the fate of bioﬁlms was
measured after co-incubation overnight. As shown in Figure 1C,
the culture supernatant of bacterium strain 273 also had strong
ability to disperse the established bioﬁlms when diluted to 1/10,
which was also conﬁrmed by analysis on glass slides (Figure 1D).
Based on above results, we concluded that the culture
supernatant of marine bacterium strain 273 had strong
antibioﬁlm activity, which was not restricted to inhibition
of bioﬁlm formation, but also eﬀective to disperse
mature bioﬁlm by P. aeruginosa PAO1. According to the
high homology (99% identity) with marine bacterium
P. stutzeri by the 16S rRNA gene sequencing (Accession
no. KU529971), the bacterium strain 273 was designated as
P. stutzeri 273.
Purification and Identification of
Antibiofilm Component EPS273 from
P. stutzeri 273
To elucidate the active component inhibiting bioﬁlm formation
by P. aeruginosa PAO1, ammonium sulfate precipitation,
dialysis, anion exchange and gel ﬁltration were applied to
purify the active component from the supernatant of P. 273.
Surprisingly, the active component was eluted immediately
after the void volume on SuperdexTM 200 column (Figure 2A),
which indicated that the antibioﬁlm component of P. stutzeri
273 supernatant had a high molecular weight. Due to its
high molecular weight, we proposed that the active fraction
might be polysaccharide-related macromolecule. Therefore,
the polysaccharide content in the elution fractions was
checked by the phenol-sulfuric acid method. As expected,
the antibioﬁlm activity was positively related to polysaccharide
concentration (Figure 2A), which suggested that the eﬀective
component of P. stutzeri 273 might be a high-molecular-mass
polysaccharide.
To further conﬁrm this speculation, proteinase K, DNase I,
RNase A and NaIO4, were used to digest the puriﬁed
active component, respectively. As shown in Figure 2B,
treatment of the active component with proteinase K, DNase
I and RNase A had no eﬀect on its antibioﬁlm activity. In
contrast, treatment of the active component with NaIO4
signiﬁcantly reduced its antibioﬁlm activity. It is well
known that NaIO4 is able to hydrolyze polysaccharides by
oxidizing the carbons bearing vicinal hydroxyl groups and
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FIGURE 1 | Effects of Pseudomonas stutzeri 273 supernatant on biofilm formation and dispersion of P. aeruginosa PAO1. (A) Biofilm formation of
P. aeruginosa PAO1 in 96-well polystyrene plate wells in the presence or absence of 10% supernatant of P. stutzeri 273 (273S) and duplicate wells are shown.
(B) Biofilm formation of P. aeruginosa PAO1 on glass slides in the presence or absence of 10% 273S. As for the controls, the same amount of LB broth was used.
(C) Preformed biofilm dispersion of P. aeruginosa PAO1 in 96-well polystyrene plate wells in the presence or absence of 10% 273S and duplicate wells are shown.
(D) Preformed biofilm dispersion of P. aeruginosa PAO1 on glass slides in the presence or absence of 10% 273S. As for the controls, the same amount of LB broth
was used.
cleaving the C-C bonds (Mack et al., 1996; Jiang et al.,
2011). Taken together, the characteristics of antibioﬁlm
component indicated that it could be a high-molecular-weight
polysaccharide. Therefore, the active component from bacterium
strain P. stutzeri 273 was named as exopolysaccharide 273
(EPS273).
Functional Group and Monosaccharide
Composition Analyses of EPS273
The major functional groups of EPS273 were determined by FT-
IR spectroscopy, indicating a typical pattern of absorption for a
polysaccharide FT-IR of EPS273 revealed typical characteristics
of polysaccharide (Figure 3). The stretching vibration at
3290 cm−1 was ascribed to the hydroxyl group and the
weak peak at 2925 cm−1 was attributed to an asymmetrical
C-H stretching vibration of the aliphatic CH2 group, which
indicates the presence of organic substances such as proteins,
sugars etc. (Wang et al., 2015). The absorption at 1651 cm−1
resembled the ring stretching of mannose (Wang et al., 2015).
The relatively weak absorption peak at 1548 cm−1 might be
attributable to the N-H bending of amides II of proteins
(Lin et al., 2005). The absorbance peak at 1405 cm−1 was
possibly due to the symmetric stretching of the –COO− group
(Jiang et al., 2011). The absorption peaks within 1200–1000
region were assigned to the vibrations of the C-O and C-O-C
glycosidic bands (Wang et al., 2015). The absorption peak at
1078 indicated the presence of a polysaccharide (Wang et al.,
2015).
High-performance liquid chromatography traces of
the polysaccharide hydrolyzate showed monosaccharide
components of EPS273. The predominant monosaccharides
of EPS273 were glucosamine (35.4%), rhamnose (28.6%), and
glucose (27.2%). Besides the three abundant monosaccharides,
mannose was also detected at relatively low level (8.7%).
Additional, HPGPC was applied to elucidate the molecular
weight of the polysaccharide and the average molecular weight is
about 190 kDa.
Fluorescence Microscopic Observation
of Biofilm Inhibition and Dispersion by
EPS273
Since the culture supernatant of P. stutzeri 273 could greatly
inhibit bioﬁlm formation and disperse the preformed
bioﬁlm of P. aeruginosa PAO1, we also checked whether
the puriﬁed EPS273 had the similar function. As shown in
Figure 4A, the bioﬁlm formation or the preformed bioﬁlm
on glass slides were greatly reduced at the concentration
of 0.1 µg/mL puriﬁed EPS273, and almost abolished at the
concentration of 0.5 µg/mL, which was consistent with
our above results obtained from the culture supernatant of
P. stutzeri 273.
Antibiofilm and Antibacterial Assays of
EPS273 Against P. aeruginosa PAO1
Consistent ﬁndings of antibioﬁlm activity were also observed
in 96-well polystyrene with the puriﬁed EPS273. As shown in
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Figure 4B, the bioﬁlm formation was gradually reduced as the
concentration of the puriﬁed EPS273 was increased from 0.1 to
0.5 µg/mL. In order to check whether the antibioﬁlm activity
was related with the antimicrobial activity, the planktonic cells
of the wells supplemented with or without puriﬁed EPS273
were also enumerated. As shown Figure 4B, the cells in the
planktonic culture were hardly changed even the concentration
of puriﬁed EPS273 was up to 0.5 µg/mL. Based on above results,
we concluded that the antibioﬁlm activity of puriﬁed EPS273 did
not result from reducing bacterial growth.
Inhibition Activities of EPS273 on
Intercellular Adhesion, Production of
Virulence Factors, H2O2 and eDNA by
P. aeruginosa PAO1
It is well established that intercellular adhesions are critical for
bacterial bioﬁlm formation. To investigate the eﬀect of EPS273
on the cell surface interaction, P. aeruginosa PAO1 cells were
cultured in LB broth with or without EPS273 at 37◦C for 24 h. As
shown in Figure 5A, the cells cultured in broth without EPS273
FIGURE 2 | Purification and identification of active component of EPS273. (A) The profiles of the fractions in the gel filtration, which were collected and
monitored for the biofilm formation determined at OD595 nm after crystal violet staining and polysaccharide content determined at OD490 nm after the
phenol-sulfuric acid assay. (B) Effects of Proteinase K, DNase I, RNase A and NaIO4 on the activities of EPS273 inhibiting biofilm formation of P. aeruginosa PAO1.
EPS273 (0.1 µg/mL) was, respectively, treated with proteinase K (PrK) (1 mg/mL), DNaseI (100 µg/mL), RNaseA (100 µg/mL) for 1 h or NaIO4 (10 mM) for 12 h at
37◦C, then taken to measure the antibiofilm activity. Error bars represent standard deviations of three independent experiments. Error bars indicate the standard
deviations of three measurements. ∗P < 0.05 versus the control.
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FIGURE 3 | Fourier transform infrared spectrum of the purified EPS273
from P. stutzeri 273 in the range 500–4000 cm−1.
aggregated and settled to the bottom of the tube, resulting in a
visible clearing of the broth. In contrast, cells cultured in broth
containing EPS273 exhibited less settling and more cloudy. These
data suggest that EPS273 can inhibit the intercellular adhesion by
P. aeruginosa PAO1.
Pyocyanin is one of the most important factors for
infection and bioﬁlm formation by P. aeruginosa PAO1 (Das
and Maneﬁeld, 2012). Next we sought to investigate the
production of pyocyanin by P. aeruginosa PAO1 with or without
EPS273 treatment. As shown in Figure 5B, the production of
pyocyanin in cells treated with EPS273 was greatly decreased
compared with cells without EPS273 treatment. Since EPS273
inhibited pyocyanin production in P. aeruginose PAO1, we
also investigated whether EPS273 could inhibit other virulence
factors, such as exoprotease and rhamnolipid. As shown in
Figures 5C,D, production of exoprotease and rhamnolipid was
also reduced by EPS273, even when it was coincubated with
P. aeruginose PAO1 up to 72 h.
It is reported that production of pyocyanin promotes bioﬁlm
formation in P. aeruginosa via eDNA release through H2O2
mediated cell lysis (Das and Maneﬁeld, 2012). Since EPS273 can
inhibit pyocyanin production greatly, it is worth to investigate
simultaneously whether EPS273 can aﬀect H2O2 generation and
eDNA release in P. aeruginosa PAO1. As expected, EPS273
also dramatically inhibited H2O2 generation (Figure 5E) and
eDNA release (Figure 5F) of P. aeruginosa PAO1 up to 72 h.
Based on above results, we proposed that one of the main
reasons of antibioﬁlm activity of EPS273 might be due to
its inhibition activity on H2O2 and eDNA release through
decreasing pyocyanin production.
Inhibition Activities of EPS273 on
P. aeruginosa PAO1 Infection to Human
Lung Carcinosis A549 Cells and
Zebrafish Embryos
It is well known that P. aeruginosa is regarded as a serious
pathogen to chronic lung infection in cystic ﬁbrosis patient,
and pyocyanin is an important virulence factor during this
infection (Lau et al., 2004). Since EPS273 inhibited pyocyanin
production in P. aeruginosa PAO1, we next asked whether
EPS273 could depress P. aeruginosa infection to human lung
cells. To answer this question, we tested the cell death
of human lung cell line A549 by P. aeruginosa PAO1
infection in the absence or presence of EPS273. As shown
in Figure 6A, the cell death was reduced gradually (from
80 to 60%) if we preincubated P. aeruginosa PAO1 with
increased concentration of EPS273 (from 0.05 to 0.1 µg/mL)
before its infection. Moreover, the cell death by P. aeruginosa
PAO1 infection was also reduced greatly if we treated
P. aeruginosa PAO1 with EPS273 at the same time of its
infection. The assays clearly showed that P. aeruginosa PAO1
were capable of killing A549 cells, while EPS273 decreased
the killing rate regardless of preincubated or simultaneously
treated P. aeruginosa with EPS273 during the infection.
Meanwhile, EPS273 is not toxic to the human cells even
in high concentration (Figure 6B). Therefore, EPS273 could
attenuate P. aeruginosa PAO1 infection to human lung cell
A549.
Recently, the zebraﬁsh (Danio rerio) has become an important
vertebrate animal model to study the pathogen infection,
especially in its embryotic stage (Goldsmith and Jobin, 2012). In
this study, we also investigated whether EPS273 could attenuate
the infection of P. aeruginosa PAO1 to zebraﬁsh embryos.
As shown in Figure 6C, the zebraﬁsh embryos developed
very well in the absence of P. aeruginosa PAO1, while the
embryos almost terminated the development when infected by
P. aeruginosa PAO1. However, if we preincubated P. aeruginosa
PAO1 with EPS273 before infection or treated P. aeruginosa
PAO1 with EPS273 at the same time of its infection, the zebraﬁsh
embryos developed much better compared with those infected
by P. aeruginosa PAO1 without EPS273 treatment. Collectively,
we concluded that EPS273 could reduce P. aeruginosa PAO1
infection to zebraﬁsh embryos.
Antioxidant Activities of EPS273 on
Hydroxyl Radical and Superoxide Radical
EPS273 could eﬀectively inhibit the bioﬁlm formation and
infection of P. aeruginosa PAO1 to mamallain cells and
zebraﬁsh. We next sought to check the antioxidant activity
of EPS273. Antioxidant activities have been performed with
diﬀerent reaction mechanisms including free radical scavenging,
reductive capacity, binding of transition metal ion catalysts
and inhibition of chain initiation (Frankel and Meyer, 2000).
Among reactive oxygen species, hydroxyl radical is the most
reactive in chemistry and it can react with all biomacromolecules
in living cells resulting in severe damage to the adjacent
macromolecules (Zhang et al., 2013). Therefore, the ability
of EPS273 to scavenge hydroxyl radicals was investigated.
As shown in Figure 7A, EPS273 exhibited concentration-
dependent scavenging activities against hydroxyl radicals and
could scavenge hydroxyl radicals up to 50% at concentration of
60 µg/mL.
Superoxide anions are active free radical precursors that
have capacity to act in response to biological macromolecules
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FIGURE 4 | Anbibiofilm and antibacterial activity analyses of purified EPS273. (A) Florescence microscopic observation of inhibition on biofilm formation and
dispersion on preformed biofilm by EPS273. The images are representative of three separate experiments. (B) Antibacterial activity analyses of EPS273. Error bars
indicate the standard deviations of three measurements. ∗P < 0.05 versus the control.
and damage tissues through oxidative damage (Kanmani et al.,
2011). In addition, the vital role of superoxide radicals in the
formation of hydrogen peroxide, hydroxyl radical and single
oxygen that can induce oxidative damage in lipids, proteins
and DNA (Wickens, 2001). Therefore, the ability of EPS273
to scavenge superoxide radicals was investigated. As shown
in Figure 7B, EPS273 also exhibited concentration-dependent
scavenging activities against superoxide radicals which were
similar to that of hydroxyl radicals. EPS273 could scavenge
hydroxyl radicals up to 70% at concentration of 60 µg/mL
(Figure 7B).
Collectively, together with the potential antioxidant activity,
non-toxic to human cells and bioﬁlm inhibiting properties of
EPS273, we proposed that EPS273 might have the potential
applications in food and heath care related ﬁelds.
Antibiofouling Activity of EPS273 in the
Marine Environment
For the aquaculturist, the eﬀects of biofouling are largely
detrimental (Braithwaite et al., 2007). The most common way
to prevent or delay biofouling in marine aquaculture is to
coat the submerged structures and net-cages with antifouling
Frontiers in Microbiology | www.frontiersin.org 9 February 2016 | Volume 7 | Article 102
Wu et al. Antibiofilm and Anti-Infection of an Exopolysaccharide
FIGURE 5 | Effects of EPS273 on intercellular adhesion (A), the production of pyocyanin (B), exoprotease (C), rhamnolipid (D), hydrogen peroxide
(H2O2) (E) and extracellular DNA (eDNA) (F) of P. aeruginosa PAO1. The concentration of EPS273 used in the above assays is 0.1 µg/mL. Error bars indicate
the standard deviations of three measurements. ∗P < 0.05 versus the control.
paints including copper and zinc (Cotou et al., 2012), which
have lethal or sub-lethal eﬀects on farmed ﬁsh and could
aﬀect the immediate immune defense mechanism of the
exposed ﬁsh (Cotou et al., 2012). Therefore, an environment-
friendly antifouling paint additive is urgently needed. Based on
our results, marine-derived exopolysaccharide EPS273 showed
excellent antibioﬁlm characteristics in the laboratory. Next,
we asked whether this exopolysaccharide was still functional
well in the opening marine environment. To answer this
question, the antifouling abilities of paints with or without
EPS273 were tested in the ocean. The results showed that
EPS273 could eﬀectively inhibit the biofouling in the ﬁrst
week (Figure 8A) and the antibiofouling activity decreased
gradually in the second week (Figure 8B). Accordingly, the
amounts of bacteria and diatoms decreased dramatically in
the ﬁrst week with the adding of EPS273 (Figures 8C,D),
while the amounts of bacteria and diatoms increased in
the second week compared to those of the ﬁrst week,
which indicated that the antibiofouling activity of EPS273
decreased gradually as time went on in the seawater. Therefore,
how to keep antibiofouling activity of EPS273 for longer
time in the marine is our endower to solve in the next
step.
DISCUSSION
Bioﬁlm formation is a lifestyle commonly adopted by a
variety of microorganisms whether in the environment or in
clinical settings (Gnanadhas et al., 2015). Within the bioﬁlm,
pathogenic microorganisms are refractory to antibiotics,
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FIGURE 6 | Inhibition activities of EPS273 on P. aeruginosa PAO1 infection to human A549 lung cells and zebrafish embryos. (A) EPS273 inhibits
P. aeruginosa PAO1 infection to human A549 lung cells. The percent cell death was calculated using propidium iodide uptake into A549 lung cells after 8 h and
normalized to cells in the absence of EPS273, of which the cell death was set as 100%. Error bars indicate the standard deviations of three measurements.
∗P < 0.05 versus the control. (B) The cytotoxic analysis of EPS273 to A549 human lung cells. A549 human lung cells were treated with 0.1, 0.5, and 1 µg/mL of
EPS273 in the absence of P. aeruginosa PAO1. The percent cell death was calculated using uptake into A549 lung cells after 8 h and normalized to lung cells treated
with P. aeruginosa PAO1 in the absence of EPS273, of which the cell death was set as 100%. Error bars indicate the standard deviations of three measurements.
∗P < 0.05 versus the control. (C) EPS273 inhibits P. aeruginosa PAO1 infection to zebrafish embryos. Zebrafish embryos were infected with P. aeruginosa PAO1 in
the presence or absence of EPS273 and imaged after 24 h infection. All the pictures were taken with inverted microscope (Nikon TS100, Japan) at 40X.
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FIGURE 7 | Scavenging activities of EPS273 on hydroxyl radical (A) and superoxide radical (B). Error bars represent standard deviations of three
independent experiments. Error bars indicate the standard deviations of three measurements.
FIGURE 8 | Antibiofouling activity of EPS273 in marine environment. (A) and (B) are images of biofouling formation on glass slides precoated by paints with or
without EPS273 after 1 or 2 weeks in the ocean environment, respectively. (C) and (D) are the relative amounts of bacteria and diatoms from corresponding glass
slides, respectively. The amount of bacteria or diatoms from glass slides without EPS273 was set at 100%. Error bars indicate the standard deviations of three
measurements. ∗P < 0.05 versus the control.
requiring concentrations up to 1000-fold more resistant
to antibiotic treatment than the same organism growing
planktonically (Simoes et al., 2009). P. aeruginosa, a notorious
opportunistic and nosocomial pathogenic bacterium, can form
bioﬁlms on a variety of natural and man-made environments
such as natural water bodies, soil, skin, and medical/food devices
(Costerton, 2001). The ability of bioﬁlm-embedded bacteria to
resist clearance by antimicrobial agents points to the importance
of a continuous search for novel molecules with newmechanisms
of action that are eﬀective against bacterial bioﬁlm, which will
be helpful to solve the alarming ability of P. aeruginosa to resist
antibiotics (Mesaros et al., 2007).
Normally, EPS is a common component of bioﬁlm and its
production is an important feature of the mature bioﬁlm (Fux
et al., 2003). In many bacteria, increased bioﬁlm formation
often correlates with increased EPS production (Jiang et al.,
2011). However, few bacterial EPSs were recently found to
negatively regulate bioﬁlm formation. The ﬁrst antibioﬁlm
polysaccharide was discovered while studying interaction
between uropathogenic and commensal strains of Escherichia
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coli in mixed in vitro bioﬁlm (Valle et al., 2006). Later studies
suggest that some bacterial exopolysaccharides can perform
functions that inhibit or destabilize the bioﬁlm (Jiang et al.,
2011; Rendueles et al., 2013). In this study, we discovered a
marine bacterium exopolysaccharide EPS273 that not only
eﬀectively reduced P. aeruginosa PAO1 bioﬁlm formation but
also dispersed the preformed bioﬁlm. Furthermore, it inhibited
the production of virulence factor pyocyanin, thus leading to
greatly attenuated infection of P. aeruginosa PAO1 to human
lung cells and zebraﬁsh embryos.
EPS273 doesn’t exhibit bactericidal activity. Its antibioﬁlm
activity, therefore, is likely to be mediated by mechanisms other
than growth inhibition. As known that bioﬁlm persistence is
attributed to a matrix of extracellular polymeric substances
made up of polysaccharides, proteins, lipids, and extracellular
DNA (eDNA; Flemming and Wingender, 2010). A decade
ago, Whitchurch et al. (2002) discovered that eDNA is major
component of bioﬁlms formed by P. aeruginosa and is essential
for bioﬁlm formation and stability. Recently, it has been reported
that eDNA release in P. aeruginosa is promoted by pyocyanin
through the cell lysis mediated by H2O2 generation (Das and
Maneﬁeld, 2012). Furthermore, it is also reported that pyocyanin
binds to DNA and increases solution viscosity therefore unveils
a novel molecular interaction that can be used to target and
control P. aeruginosa-mediated bioﬁlm formation and its related
lung infection (Das et al., 2015). Our ﬁndings showed that
EPS273 inhibited not only the production of the virulence
factor pyocyanin but also the generation of H2O2 and eDNA in
P. aeruginosa PAO1. Along with its antibioﬁlm characteristic, we
speculated that EPS273 might inhibit the bioﬁlm formation by
P. aeruginosa PAO1 via decreasing the production of pyocyanin,
then consequently inhibiting the generation of H2O2 and
release of eDNA, which are essential for bioﬁlm formation
and stability. To our best knowledge, this is the ﬁrst cut-
in to reveal the antibioﬁlm mechanism of marine bacterium
exopolysaccharide.
One of the notable characteristic of EPS273 is that it can
eﬀectively disperse the preformed bioﬁlm (Figures 1 and 4).
Several diﬀerent mechanisms have been implicated in the bioﬁlm
dispersion, including cell death, matrix-degrading enzymes, and
induction of cellular motility (Karatan and Watnick, 2009;
Kaplan, 2010). Several antibioﬁlm polysaccharides have also
been shown to enhance or trigger bioﬁlm dispersal (Bendaoud
et al., 2011; Jiang et al., 2011). In spite of recent research
on the mechanisms of action of antibioﬁlm polysaccharides
and other biosurfactants, the precise mechanisms by which
they break-down preformed bioﬁlms are yet to be elucidated
(Rendueles et al., 2013). Therefore, it will be very interesting
to reveal the detailed antibioﬁlm mechanisms of EPS273 in the
future.
In recent years, polysaccharides from bacteria, yeast, fungi,
and medicinal plants have been reported to possess antioxidant
activities and could be used as natural antioxidant for
the development of eﬀective and non-toxic medicines with
stronger antioxidant activities in vitro and in vivo (Zhang
et al., 2013; Li et al., 2014). Notably, it is reported that
exopolysaccharides isolated from Acinetobacter sp., Streptococcus
sp., and Pseudomonas sp. have been used for food and health
care products (Kumar et al., 2007; Delbarre-Ladrat et al., 2014).
Furthermore, in the last decade, several products from P. stutzeri,
P. fluorescens, and P. amyloderamosa have successfully entered
the Generally Recognized as Safe (GRAS) Notice Inventory2.
Our ﬁndings showed that EPS273 exhibited strong antioxidant
potential by quenching hydroxyl and superoxide anion radicals,
and also protected human lung epithelial cells and zebraﬁsh
embryos from killing by P. aeruginosa PAO1. As we mentioned
before, P. aeruginosa is regarded as a notorious nosocomial
pathogen and a major food spoilage microorganism in food
processing industry, along with the strong antibioﬁlm activity
of EPS273 against P. aeruginosa, we believe that EPS273 might
have the potential to be used in the food and healthcare
industry.
The frequent occurrence of biofouling in marine aquaculture
is a signiﬁcant challenge resulting in increased operational
expenses and deleterious impacts on the species being cultured
(Fitridge et al., 2012). The control of biofouling in aquaculture
is achieved through using copper/zinc containing antifouling
paint. However, the continued increasingly stringent legislation
for biocides in food production necessitates the development
of environmental and societal antifouling agents eﬀectively
preventing the settlement and growth of resilient multi-
species consortia of biofouling organisms in the opening ocean
environment (Fitridge et al., 2012). Unfortunately, marine
condition is much more complicated than that in the laboratory,
which makes most of the environmental friendly antibiofouling
compounds lose their function when tested in the ocean. Notably,
EPS273 shows great antibiofouling eﬀects to both bacteria and
diatoms up to 2 weeks, which indicates that EPS273 maybe
suitable to develop environmental friendly antibiofouling agents
in aquaculture.
It is reported that the bioﬁlm formation, the virulence
factors production and the antioxidants are closely related
(Das and Maneﬁeld, 2012; Das et al., 2015). In our study,
just as Das et al. (2015) reported, the exopolysaccharide
EPS273 not only could inhibit bioﬁlm formation and
disperse preformed bioﬁlm, but also has inhibition
activity on the production of virulence factors and also
has antioxidant activity by scavenging of free radicals.
Therefore, these properties of EPS273 make it potential for
the treatment and prevention of bioﬁlm-related infection,
food-processing contamination and the biofouling in marine
aquaculture.
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